VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
5667
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
907
Interactions with Platform & by Email
PARTICIPANTS
172
Unique # Participated
VALIDATIONS
77
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
108
PAGES
177
EDITION
16
PRICE
USD $5450
Focus On Laboratory Testing, One of the Largest Segments in the Cardiac Biomarkers Market.
Will this Market be a Huge Opportunity by 2025?
COVID-19 IMPACT SURVEY
GLOBAL EXECUTIVE SURVEY
Impact of Pandemic & Economic Slowdown
Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.
Amid the COVID-19 crisis, the global market for Cardiac Biomarkers estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$10.8 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Laboratory Testing, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$6.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing segment is readjusted to a revised 8.8% CAGR for the next 7-year period.
The Cardiac Biomarkers market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.We bring years of research experience to this 16th edition of our report. The 177-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Diagnostics; Beckman Coulter Inc.; BG Medicine; bioMérieux SA; Boditech Med Inc.; Labsystems Diagnostics OY; LifeSign LLC; LSI Medience Corp.; Merck KGaA; Ortho-Clinical Diagnostics Inc.; Quidel Corporation; Randox Laboratories; Response Biomedical Corp.; Roche Diagnostics Corp.; Siemens Healthineers
» Location Type (Laboratory Testing, Point-of-Care Testing)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| A Curtain Raiser |
| Major Cardiac Markers and their Properties |
| Recent Market Activity |
| Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations |
| North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum |
| Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction |
| Analysis by Type of Cardiac Biomarker Assay/Test |
| Competitive Landscape |
| Intense Competition among Players in the Cardiac Diagnostics Market |
| Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits |
| Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands |
| Other Recent Innovations |
| Lipid Biomarker Panel to Detect HfrEF |
| VectraplexECG System with CEB® Cardiac Electrical Biomarker |
| Cardiac Biomarkers on Smartphone |
| Stringent Regulations and Other Challenges |
| Global Competitor Market Shares |
| Cardiac Biomarkers Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Diagnostics, Inc. (USA) |
| Quidel Corporation (USA) |
| Beckman Coulter, Inc. (USA) |
| BG Medicine, Inc. (USA) |
| biomérieux SA (France) |
| Boditech Med Inc. (South Korea) |
| Labsystems Diagnostics OY (Finland) |
| LifeSign LLC (USA) |
| LSI Medience Corporation (Japan) |
| Ortho-Clinical Diagnostics, Inc. (USA) |
| Randox Laboratories Ltd. (UK) |
| Response Biomedical Corp. (Canada) |
| Roche Diagnostics (Switzerland) |
| Siemens Healthineers (USA) |
| Merck KGaA (Germany) |
| 3. MARKET TRENDS & DRIVERS |
| The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease |
| Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs |
| Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis |
| Commercialization of Novel Biomarkers to Drive Market Growth |
| Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers |
| Cardiac Biomarkers - A Powerful Tool for Patient Triaging |
| Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays |
| Government Support Instrumental for Boosting Market Momentum |
| Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias |
| High-Performance Techniques Drive Biomarker Discovery in Cardiology |
| Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment |
| Biomarkers - A Promising Diagnostic Tool for ACS |
| Biomarker Discovery for ACS to Undergo Significant Changes |
| Cardiac Biomarker Play Critical Role in Stroke Diagnosis |
| Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment |
| Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth |
| 4. GLOBAL MARKET PERSPECTIVE |
| Cardiac Biomarkers Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Cardiac Biomarkers Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Cardiac Biomarkers Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Laboratory Testing (Location Type) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Laboratory Testing (Location Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Laboratory Testing (Location Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Point-of-Care Testing (Location Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Point-of-Care Testing (Location Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Point-of-Care Testing (Location Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Cardiac Biomarkers Market Share (in %) by Company: 2020 & 2025 |
| United States Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2018 to 2025 |
| Cardiac Biomarkers Market in the United States by Location Type: A Historic Review in US$ Thousand for 2009-2017 |
| United States Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018 to 2025 |
| Canadian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2009-2017 |
| Cardiac Biomarkers Market in Canada: Percentage Share Breakdown of Sales by Location Type for 2009, 2019, and 2025 |
| Japan |
| Japanese Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Market in Japan: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2009-2017 |
| Japanese Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| China |
| Chinese Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Historic Market Analysis in China in US$ Thousand by Location Type: 2009-2017 |
| Chinese Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Europe |
| Market Facts & Figures |
| European Cardiac Biomarkers Market: Competitor Market Share Scenario (in %) for 2020 & 2025 |
| European Cardiac Biomarkers Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Cardiac Biomarkers Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Cardiac Biomarkers Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018-2025 |
| Cardiac Biomarkers Market in Europe in US$ Thousand by Location Type: A Historic Review for the Period 2009-2017 |
| European Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| France |
| Cardiac Biomarkers Market in France by Location Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2009-2017 |
| French Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Germany |
| Cardiac Biomarkers Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| German Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| German Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Historic Market Analysis in Italy in US$ Thousand by Location Type: 2009-2017 |
| Italian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| United Kingdom |
| United Kingdom Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2009-2017 |
| United Kingdom Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Spain |
| Spanish Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018 to 2025 |
| Spanish Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2009-2017 |
| Cardiac Biomarkers Market in Spain: Percentage Share Breakdown of Sales by Location Type for 2009, 2019, and 2025 |
| Russia |
| Russian Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2018 to 2025 |
| Cardiac Biomarkers Market in Russia by Location Type: A Historic Review in US$ Thousand for 2009-2017 |
| Russian Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018-2025 |
| Cardiac Biomarkers Market in Rest of Europe in US$ Thousand by Location Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Asia-Pacific Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Cardiac Biomarkers Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017 |
| Asia-Pacific Cardiac Biomarkers Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Cardiac Biomarkers Market in Asia-Pacific by Location Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2009-2017 |
| Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Australia |
| Cardiac Biomarkers Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| Australian Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| Australian Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| India |
| Indian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018 to 2025 |
| Indian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2009-2017 |
| Cardiac Biomarkers Market in India: Percentage Share Breakdown of Sales by Location Type for 2009, 2019, and 2025 |
| South Korea |
| Cardiac Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| South Korean Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| Cardiac Biomarkers Market Share Distribution in South Korea by Location Type: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2009-2017 |
| Rest of Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Cardiac Biomarkers Market Trends by Region/Country in US$ Thousand: 2018-2025 |
| Cardiac Biomarkers Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Cardiac Biomarkers Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Historic Market Analysis in Latin America in US$ Thousand by Location Type: 2009-2017 |
| Latin American Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Argentina |
| Argentinean Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018-2025 |
| Cardiac Biomarkers Market in Argentina in US$ Thousand by Location Type: A Historic Review for the Period 2009-2017 |
| Argentinean Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Brazil |
| Cardiac Biomarkers Market in Brazil by Location Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Brazilian Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2009-2017 |
| Brazilian Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Mexico |
| Cardiac Biomarkers Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| Mexican Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| Mexican Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Rest of Latin America Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2018 to 2025 |
| Cardiac Biomarkers Market in Rest of Latin America by Location Type: A Historic Review in US$ Thousand for 2009-2017 |
| Rest of Latin America Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Cardiac Biomarkers Market in the Middle East by Region/Country in US$ Thousand: 2009-2017 |
| The Middle East Cardiac Biomarkers Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018 to 2025 |
| The Middle East Cardiac Biomarkers Historic Market by Location Type in US$ Thousand: 2009-2017 |
| Cardiac Biomarkers Market in the Middle East: Percentage Share Breakdown of Sales by Location Type for 2009, 2019, and 2025 |
| Iran |
| Iranian Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Market in Iran: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2009-2017 |
| Iranian Cardiac Biomarkers Market Share Analysis by Location Type: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2018-2025 |
| Cardiac Biomarkers Market in Israel in US$ Thousand by Location Type: A Historic Review for the Period 2009-2017 |
| Israeli Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Saudi Arabia |
| Saudi Arabian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2018-2025 |
| Cardiac Biomarkers Historic Market Analysis in Saudi Arabia in US$ Thousand by Location Type: 2009-2017 |
| Saudi Arabian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| United Arab Emirates |
| Cardiac Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| United Arab Emirates Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| Cardiac Biomarkers Market Share Distribution in United Arab Emirates by Location Type: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Cardiac Biomarkers Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2018-2025 |
| Rest of Middle East Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2009-2017 |
| Rest of Middle East Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| Africa |
| African Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2018 to 2025 |
| Cardiac Biomarkers Market in Africa by Location Type: A Historic Review in US$ Thousand for 2009-2017 |
| African Cardiac Biomarkers Market Share Breakdown by Location Type: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 47 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com